Keros Therapeutics, Inc.
SEC Filing List
KROS CIK: 0001664710
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | Toppan Merrill/FA | 05/15/2026 | |||
| 8-K | Current report filing | Keros Therapeutics, Inc. | 05/14/2026 | ||
| 10-Q | Quarterly report pursuant to Section 13 ... | Keros Therapeutics, Inc. | 05/14/2026 | ||
| ARS | Annual report to security holders | Keros Therapeutics, Inc. | Toppan Merrill/FA | 04/22/2026 | |
| DEFA14A | Definitive additional proxy soliciting m... | Keros Therapeutics, Inc. | Toppan Merrill/FA | 04/22/2026 | |
| DEF 14A | Definitive proxy statements | Keros Therapeutics, Inc. | Toppan Merrill/FA | 04/22/2026 | |
| 4 | Statement of changes in beneficial owner... | Bienaime Jean Jacques | Keros Therapeutics, Inc. | 04/17/2026 | |
| SCHEDULE 13G | 04/07/2026 | ||||
| 4 | Statement of changes in beneficial owner... | Seehra Jasbir | Keros Therapeutics, Inc. | 04/06/2026 | |
| 144 | Filing for proposed sale of securities u... | Allen Overy Shearman Sterling LLP /fa | 03/31/2026 | ||
| No record found. | |||||
| Load More | |||||
